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To evaluate cytokine balance related to cardiopulmonary bypass, we 
prospectively investigated 11 infants undergoing cardiac operations for 
congenital heart disease. Proinflammatory c tokines (tumor necrosis fac- 
tor-a and interleukin-8) and the antiinflammatory c tokine interleukin-10 
were measured at multiple time points before, during, and after bypass. 
Tumor necrosis factor-~ and interleukin-8 values were within normal range 
before the operation. These values increased significantly during bypass, 
reaching their peaks after protamine administration (tumor necrosis 
factor-s, 133.6 +- 124.9 pg/ml; mean _ standard eviation; p < 0.005) and 
2 hours after termination of the procedure (interleukin-8, 92.1 +-- 44.1 
pg/ml; p < 0.01). Tumor necrosis factor-or and interleukin-8 equaled 
normal prebypass values from the first postoperative day on. Interleukin-10 
levels were within normal range before the operation and were already 
significantly increased 10 minutes after initiation of bypass (interleukin-10, 
39.4 + 34.3 pg/ml; p < 0.05). These levels remained elevated throughout the 
procedure but returned to normal after protamine administration. A 
second significant release of interleukin-10 occurred from the early post- 
operative period on, reaching its peak 24 hours after termination of 
cardiopulmonary b pass (interleukin-10, 351.6 - 304.0 pg/ml; p < 0.01). 
Interleukin-10 values were normal on the second postoperative day in all 
patients. Interleukin-10 kinetics showed an inverse pattern compared with 
tumor necrosis factor-~ and interleukin-8. This difference suggests an 
interplay between proinflammatory and antiinflammatory c tokines re- 
leased during and after cardiopulmonary b pass. Interleukin-10 levels 
measured 4 and 24 hours after bypass trongly correlated with the degree 
of hypothermia during bypass (Spearman's correlation coefficient, -0.77 
[p < 0.01] and -0.89 [p < 0.0005], respectively); these levels did not 
correlate with duration of bypass and aortic crossclamping, however. This 
result suggests that besides immunologically mediated production of 
interleukin-10, hypothermia itself could modulate interleukin-10 produc- 
tion. In conclusion, this study demonstrates interleukin-10 production, in 
addition to interleukin-8 and tumor necrosis factor-or synthesis, in re- 
sponse to cardiopulmonary b pass in infants. Interleukin-10 could play a 
protective role by down-regulating proinflammatory c tokine release dur- 
ing and after cardiopulmonary b pass. (J THORAC CARDIOVASC SURG 1996; 
111:545-53) 
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C ardiopulmonary bypass (CPB) induces complex 
inflammatory mechanisms, including the synthe- 
sis of proinflammatory cytokines such as tumor 
necrosis factor-c~ (TNF-o0, interleukin (IL)-I, IL-6, 
and IL-8, all of which may be related in part to 
postoperative complications. 1-5 Several stimuli (in- 
cluding complement anaphylatoxins produced dur- 
ing CPB 6' 7) induce TNF-a synthesis by activated 
monocytes and macrophages. 8 TNF-o~ plays a major 
role in the pathophysiology of sepsis 8and is thought 
to be implicated in the development of complica- 
tions after cardiac operations, uch as capillary leak 
syndrome and multisystem organ failure. 1' 9 IL-8 is 
produced by several circulating and noncirculating 
cells in response to stimuli, such as IL-1 and TNF- 
a. 1° IL-8 is a potent polymorphonuclear and T-lym- 
phocyte chemotactic factor that increases endothelial 
cell-polymorphonuclear leukocyte interactions. 11 Be- 
cause of its increased synthesis by monocytes submit- 
ted to anoxic preconditioning and oxygen stress, IL-8 
may play a role in ischemia-reperfusion injury. 12 
Whether the synthesis of antiinflammatory inter- 
leukins a3 controls the production of proinflamma- 
tory cytokines in the setting of CPB remains un- 
known. IL-10, a recently characterized natural 
antiinflammatory interleukin, regulates the func- 
tion of several cell types. 14' 15 IL-10 suppresses the 
in vitro production of TNF-a, IL-1, IL-6, and IL- 
8, ~6'17 as well as its own production. 18 It also 
enhances the lipopolysaccharide-induced macro- 
phage production of the IL-1 receptor antagonist. 19
In a murine model of sepsis, IL-10 reduces lipo- 
polysaccharide-related toxicity 2° and, in vitro, IL-10 
inhibits the induction of monocyte procoagulant 
activity by bacterial lipopolysaccharides. 21 IL-10 also 
blocks up-regulation of pulmonary vascular intracel- 
lular adhesion molecule-1 in an animal model of 
immune complex-induced lung injury. 22 IL-10 is 
produced uring sepsis, 23' 24 and the role of TNF-a 
as a mediator for its synthesis in human endotox- 
emia has been addressed. 25Recently, IL-10 secre- 
tion in adult patients undergoing CPB has been 
observed. 26 
The aim of our study was to analyze cytokine 
balance related to CPB in infants by measuring the 
secretion of the antiinflammatory IL-10 in addition 
to the secretion of the proinflammatory c tokines 
TNF-a and IL-8. 
Patients and methods 
Clinical. Eleven infants aged 2 to 10 months (median 3 
months) undergoing CPB for congenital cardiac defects 
were prospectively enrolled in this study. Patient data and 
type of surgical procedure are shown in Table I. 
Anesthesia and CPB protocol. Conventional general an- 
esthesia nd curarization, achieved with diazepam, fen- 
tanyl sulfate, and pancuronium bromide, were used in all 
patients. Nasotracheal intubation and placement of cen- 
tral venous and peripheral arterial catheters were per- 
formed after induction of anesthesia. At the end of the 
surgical procedure, left atrial and pulmonary arterial 
catheters were placed if necessary for postoperative care. 
Antibiotic prophylaxis consisted of cefazolin (25 mg/kg) at 
induction of anesthesia nd at the end of the surgical 
procedure. Patients did not receive corticosteroids uring 
the study period. 
CPB was conducted according to the previously de- 
scribed technique. 27In brief, a roller pump inducing a 
nonpulsating flow, a hollow fiber membrane oxygenator, 
and a heat exchanger for cooling and rewarming were 
used. Priming volume consisted of compatible packed red 
cells, fresh frozen plasma, and sodium bicarbonate 
(8.4%). CPB was established after aortic and bicaval 
cannulation with a flow rate of 2.4 L/m 2 per minute, which 
was maintained throughout the procedure. A left ventric- 
ular vent was placed through the right superior pulmon- 
ary vein. After aortic crossclamping, cardioplegia was 
achieved with an intraaortic injection of Bretschneider's 
solution (5 to 10 ml/kg) followed 30 minutes later by an 
injection of a Ringer's lactate potassium solution (15 
ml/kg) with oxygenated blood (5 ml/kg). Heparinization 
was achieved with heparin sulfate (3 mg/kg) and its effects 
were neutralized at the end of the procedure with prota- 
mine sulfate, which was titrated according to the mea- 
sured circulating heparin level. 
Postoperative care. Patients were cared for in the pedi- 
atric intensive care unit. Continuous monitoring of hemo- 
dynamic parameters (heart rate and rhythm and systemic 
arterial, central venous, pulmonary arterial, and left atrial 
pressures) and measurement of urine output were contin- 
ued for as long as necessary, but at least for 24 hours. 
Inotropic and systemic or pulmonary vasodilator treat- 
ment (or both) were adapted to hemodynamic parame- 
ters. Routine blood examinations included blood gas 
analysis, determination f serum electrolyte values, and 
coagulation tests (thrombin time, partial thromboplastin 
time, fibrinogen, thrombocyte count). Aspartate amin- 
otransferase was repeatedly measured uring the first 3 
days after the operation. The ratio of arterial oxygen 
tension (Pao2) to inspired oxygen fraction (Fio2) was used 
as the oxygenation parameter in patients receiving me- 
chanical ventilation. 
Cytokine determination. TNF-a, IL-8, and IL-10 were 
determined by means of an immunoenzymetric assay from 
Medgenix, Fleurus, Belgium, according to the manufac- 
turer's recommendations. It is a solid-phase enzyme- 
amplified sensitivity immunoassay performed on microti- 
ter plates, based on the oligoclonal system, in which 
several monoclonal antibodies directed against distinct 
epitopes of the cytokines are used, allowing high sensitiv- 
ity. Specificity of the assays has been controlled by the 
manufacturer by excluding cross reactivity toward 25 
cytokines or growth factors. Accuracy of the determina- 
tions was also controlled by demonstrating greater than 
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Table I. Patient data 
Patient No. Age (mo) Diagnosis Surgical procedure Postop. complications 
1 3.5 DORV, large VSD, PAB VSD closure, debanding Heart failure 
2 2.5 VSD, PHT VSD closure None 
3 4.5 VSD, PHT VSD closure None 
4 8.5 Down, AVSD, PHT AVSD repair None 
5 10 Tetralogy of Fallot Repair None 
6 3 Down, AVSD, PHT AVSD repair PHT 
7 2.5 Down, AVSD, PHT AVSD repair Heart failure, PHT 
8 2.5 Down, AVSD, PHT AVSD repair Heart failure, PHT, CLS, DIC 
9 4 VSD, PHT VSD closure None 
10 2 VSD, PHT VSD closure None 
11 8 Tetralogy of Fallot Repair None 
DORV, Double-outlet right ventricle; VSD, ventricular septal defect; PAB, pulmonary arterial banding; PHT, pulmonary hypertension; Down, Down 
syndrome; AVSD, atrioventricular septal defect; CLS, capillary leak syndrome; DIC, disseminated intravascular coagulation. 
95% recovery when purified cytokine was purposely added 
in samples of plasma, serum, or cell culture medium in 
concentration ranges covering the entire spectrum of the 
standard curve (up to 1500 pg/ml for TNF-cg up to 750 
pg/ml for IL-8, and up to 1335 pg/ml for IL-10). In each 
test run, control samples with known concentrations were 
assessed in the low- and high-range levels of the assay. 
The minimum detectable concentrations are 3 pg/ml for 
TNF-c~, 0.7 pg/ml for IL-8, and 1 pg /ml for IL-10. In 
plasma of normal adults, expected TNF-a values are less 
than 20 pg/ml, IL-8 values range between 0 and 47 pg/ml, 
and IL-10 values average 2.45 +_ 3.2 pg/ml (mean _+ 
standard eviation). 
Blood samples were collected after induction of anes- 
thesia, 10 minutes after the onset of CPB, 5 minutes after 
removal of the aortic crossclamp, at the end of CPB 
before protamine administration, 10 minutes after prota- 
mine administration, and 2, 4, 12, 24, and 48 hours after 
termination of CPB. Blood was withdrawn from a periph- 
eral arterial catheter before and after CPB and simulta- 
neously from the arterial ine and the left vent during 
CPB. For each sample, 1 ml of blood was taken in plastic 
tubes containing ethylenediaminetetraacetic acid. Blood 
was immediately centrifuged (3000 rpm for 10 minutes) 
and separated plasma was frozen at -70 ° C until assay. 
Statistical analysis. Results are expressed in the text 
and in Table II as the mean value _+ 1 standard eviation 
and in the figures as the mean value -+ standard error of 
the mean. Data were analyzed with SYSTAT software 
(The System for Statistics, SYSTAT, Inc., 1990, Evanston, 
Ill.). For statistical analysis of cytokine variation in com- 
parison with prebypass values, the nonparametric Wil- 
coxon test was used. Spearman's rank correlation coeffi- 
cient was assessed for correlation of independent 
parameters, and p values less than 0.05 were considered 
significant. 
Results 
Clinical. Durations of CPB and aortic cross- 
clamping were 96.8 _ 40.5 minutes (mean _ stan- 
dard deviation) and 53.7 + 24.1 minutes, respec- 
tively. Minimal rectal temperature averaged 27.6 _+ 
Table II. Clinical data 
CPB (min) 96.8 +- 40.5 
AXT (min) 53.7 -+ 24.1 
Temperature (°C) 27.6 -+ 2.3 
Inotropic support (n) 3 
Pulmonary vasodilator (n) 3 
Pao2/Fio 2(H2) 25.7 _+ 14.3 
Pao2/Fio 2 (H4) 26.7 _+ 11.3 
Pao2/Fi% (H12) 27.7 _+ 18.1 
Mechanical ventilation (hr) 222 _+ 308 
CPB, Duration of cardiopulmonary b pass; AXZ, duration of aortic 
crossclamping; temperature, minimal rectal temperature; Paoe/Fio2 (H2), 
(H4), (H12), Paoz/Fio2 , 4, and 12 hours after termination of CPB. 
Results are expressed by the mean value _+ standard eviation. 
2.3 ° C. No correlation was observed between dura- 
tion of CPB, duration of aortic crossclamping, and 
minimal rectal temperature during CPB. Three pa- 
tients with postoperative heart failure (patients 1, 7, 
and 8) received inotropic support, and three pa- 
tients with pulmonary hypertension (patients 6, 7, 
and 8) received pulmonary vasodilator treatment. 
The ratio Pao2/Fio2 calculated at several time points 
during the first postoperative day is shown in Table 
II. Lungs of the patients were mechanically venti- 
lated for 222 _+ 308 hours (median 84 hours). 
Maximal aspartate aminotransferase values mea- 
sured within the first 12 hours after the operation 
averaged 188 + 74 IU/L. Important capillary leak 
syndrome developed in patient 9, with laboratory 
evidence of disseminated intravascular coagulation. 
All infants were discharged home. Table I I  summa- 
rizes clinical data of our patients. 
Circulating cytokines. The perioperative cytokine 
values were obtained from blood samples obtained 
from peripheral arterial and oxygenator arterial ines. 
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Fig. 1. Course of TNF-a before, during, and after CPB in 11 infants. Values are expressed by mean -+ 
standard error of the mean. *Significant differences in TNF-a levels versus prebypass values (p < 0.05). 
CPB, Cardiopulmonary b pass; AXC, aortic crossclamp time. For specification of sample times, see text. 
The transpulmonary c tokine gradient during CPB is 
specified. 
TNF-a. TNF-a concentrations rose significantly 
during CPB (prebypass values 26.5 _+ 9.7 pg/ml, 
mean _+ standard deviation) to peak values 10 
minutes after administration of protamine (136.6 _ 
124.9 pg/ml; p < 0.005). TNF-a concentrations 
decreased from the immediate postoperative p riod 
on and reached prebypass values on the first post- 
operative day. During CPB, no transpulmonary 
TNF-a gradient was present. There was no correla- 
tion between TNF-a values and minimal tempera- 
ture, duration of CPB, and duration of aortic cross- 
clamping. TNF-a levels measured 4 and 24 hours 
after CPB correlated with maximal concentrations 
of aspartate aminotransferase (Spearman's correla- 
tion coefficient, 0.69 and 0.86, respectively; p < 
0.05). Fig. 1 shows the course of TNF-a before, 
during, and after CPB. 
IL-8. IL-8 concentrations rose significantly dur- 
ing CPB from prebypass values (9.0 _+ 5.7 pg/ml, 
mean _+ stamdard eviation) to peak values 2 hours 
after termination of CPB (92.1 _+ 44.1 pg/ml; p < 
0.01). IL-8 concentration decreased slowly on the 
day of operation and reached pre-CPB values from 
the first postoperative day on. During CPB, no 
transpulmonary IL-8 gradient was present. No cor- 
relation existed between IL-8 levels and minimal 
temperature or duration of CPB and aortic cross- 
clamping. IL-8 levels did not correlate with the 
Pao2/Fio 2ratio calculated uring the study period or 
with the duration of mechanical ventilation. IL-8 
measured 12 and 24 hours after CPB correlated with 
maximal aspartate aminotransferase (Spearman's 
correlation coefficient, 0.62; p < 0.05). Fig. 2 depicts 
the course of IL-8 before, during, and after CPB. 
IL-10. IL-10 increased significantly from preby- 
pass values to values 10 minutes after the start of 
CPB (8.4 2 4.9 pg/ml [mean _+ standard eviation] 
vs 39.4 _+ 34.3 pg/ml; p < 0.02), remaining elevated 
after removal of the aortic crossclamp and at the 
end of CPB. IL-10 values after protamine adminis- 
tration tended to return to normal. In comparison 
with prebypass values, IL-10 levels were significantly 
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Fig. 2. Course of IL-8 before, during, and after CPB in 11 infants. Values are expressed by mean _+ 
standard error of the mean. *Significant differences in IL-8 levels versus prebypass values (p < 0.05). CPB, 
Cardiopulmonary b pass; AXC, aortic crossclamp time. For specification of sample times, see text. 
increased 4 hours after termination of CPB (p < 
0.05), reaching their peak values 24 hours after CPB 
(351.6 _+ 304.0 pg/ml;p < 0.02). IL-10 levels were in 
the normal range on the second postoperative day. 
Fig. 3 shows the course of IL-10 before, during, and 
after CPB. No significant transpulmonary difference 
in IL-10 levels was noted during CPB. IL- 10 levels 
4 and 24 hours after termination of CPB correlated 
negatively with the minimal rectal temperture dur- 
ing CPB (Spearman's correlation coefficient, -0.77 
[p < 0.01] and -0.89 [p < 0.0005], respectively). Fig. 
4 shows the relationship between IL-10 measured 24 
hours after CPB and minimal rectal temperature 
during CPB. IL-10 levels did not correlate with 
duration of CPB or aortic crossclamping. There was 
no correlation between IL-10 levels and TNF-a or 
IL-8 levels during or after CPB. IL-10 levels mea- 
sured 4 and 24 hours after completion of CPB 
correlated with Pao2/Fio 2 ratio calculated 12 hours 
after the operation (Spearman's correlation coeffi- 
cient, -0.80 [p < 0.01] and -0.87 [p < 0.005], 
respectively). Fig. 5 shows the relationship between 
IL-10 measured 24 hours after CPB and Pao2/Fio2 
ratio calculated 12 hours after the operation. 
Discussion 
This study demonstrates cytokine balance related 
to CPB in infants undergoing cardiac operations. It
confirms previous reports on TNF-a and IL-8 liber- 
ation during and after CPB. 1'4'5'28-3° Data on 
TNF-a release remain nonetheless controver- 
sial. 2s-3° The reason for the inconsistent systemic 
detection of this cytokine independent of the tem- 
perature regimen during CPB is not clear. In agree- 
ment with others, 2'3, 28-3o we observed a large inter- 
individual variation in TNF-a and IL-8 production. 
Interindividual differences in TNF-o~ production are 
discussed in terms of genetic predisposition. 31 In our 
series, patterns of TNF-a and IL-8 release were 
similar, with progressive cytokine increase up to a 
peak value reached after protamine administration 
and 2 hours after termination of CPB, respectively, 
followed by the fall and normalization of these 
values from the first postoperative day on. These 
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parallel kinetics suggest he role of a common 
stimulatory mechanism acting early during CPB on 
cells producing TNF-a and IL-8. This mechanism 
could be complement activation with liberation of 
complement anaphylatoxins, the release of which 
always precedes the production of proinflammatory 
cytokines in the setting of CPB. 2' 3 Cellular sources 
of TNF-a are mainly monocytes and macrophages, 
whereas IL-8 is also produced by neutrophils, endo- 
thelial cells, and numerous noncirculating cell 
types.a, i0 The absence of a significant TNF-a and 
IL-8 transpulmonary gradient during CPB in our 
patients--in particular after removal of the aortic 
crossclamp--excludes a predominant role of the 
pulmonary endothelium and pulmonary macroph- 
ages in the uptake or systemic release (or both) 
of those cytokines. Furthermore, the rapid increase 
of TNF-a and IL-8 after removal of the aortic 
crossclamp and the initiation of rewarming support 
the view that rewarming and ischemia-reperfusion 
mechanisms could be responsible, at least in part, 
for both the systemic TNF-a and IL-8 release. 12' 29, 30 
In our series, TNF-a and IL-8 levels measured 
during the first postoperative day correlated with 
maximal aspartate aminotransferase values. This 
relationship supports the suspected role of TNF-a in 
postoperative organ failure. 9 Furthermore, it sug- 
gests that IL-8, by its chemotactic properties that 
might induce degranulation of stimulated neutro- 
phils and proteolytic enzyme release, 1°' 2s could also 
be implicated in postoperative tissue damage. 
In addition to the production of proinflammatory 
cytokines related to CPB, our results clearly dem- 
onstrate significant secretion of the antiinflamma- 
tory cytokine IL-10. In contrast o the release of 
TNF-a and IL-8, the pattern of IL-10 release was 
biphasic. A first significant peak of circulating IL-10 
was observed as early as 10 minutes after induction 
of CPB. IL-10 levels then remained elevated until 
the end of CPB. Inasmuch as IL-10 is not detectable 
in plasma of healthy adults, 23 admixture of IL-10 by 
the priming solution appears to be excluded here. 
Therefore our observation suggests immediate lib- 
eration of constitutive IL-10 from stimulated cells 
producing IL-10. TM Cellular sources of IL-10 are 
mainly cells from the monocyte-macrophage lin- 
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eage, but other circulating and noncirculating cells 
such as T- and B-lymphocytes and keratinocytes are 
also recognized as synthesizing IL-10.18 Pulmonary 
macrophages did not play an exclusive role in early 
IL-10 production in our patients, inasmuch as we 
did not observe a significant transpulmonary gradi- 
ent of this interleukin during CPB. The stimulatory 
mechanism for the early IL-10 release that occurred 
independently from systemic TNF-oz and IL-8 liber- 
ation remains at this time unclear. It must be 
mentioned that circulating cytokines do not strictly 
reflect local production, because their typical action 
is autocrine or paracrine and not endocrine. 13IL-10 
is a pleiotropic antiinflammatory cytokine that de- 
activates monocytes and macrophages and inhibits 
the synthesis of proinflammatory c tokines uch as 
TNF-o~ and IL-8.16' 17, 20 As suggested by the inverse 
pattern of the kinetics of both TNF-a and IL-8 on 
the one hand and IL-10 on the other hand, early 
IL-10 liberation during CPB could have modulated 
subsequent proinflammatory cytokine release. 
A second IL-10 peak was observed 24 hours after 
termination ofCPB. IL-10 levels rose from the early 
postoperative p riod on, clearly after the peak con- 
centrations of TNF-o~ and IL-8 were observed. This 
delayed IL-10 release most probably corresponds to
the classic pattern for inducible cytokines. 13In our 
series, the inducing stimulus could well have been 
TNF-~, which, in contrast to other cytokines such as 
IL-I~, IL-1]3, and IL-6, has been shown to have a 
predominant role in human monocyte IL-10 synthe- 
sis. 24 
Our results howing significant IL-10 release per- 
sisting 24 hours after CPB contrast with a recent 
observation i  adult patients, in whom weak and 
transient IL-10 release occurred in response to CPB 
performed under moderate hypothermia. In this 
series, pretreatment with corticosteroids signifi- 
cantly increased IL-10 production, suggesting a
modulatory effect of corticosteroids on IL-10 syn- 
thesis. 26 The strong relationship we observed be- 
tween circulating IL-10 levels both 4 and 24 hours 
after the operation and minimal rectal temperature 
measured during CPB, but not duration of CPB and 
aortic crossclamping, suggest that hypothermia per 
se could modulate IL-10 production. Thus temper- 
ture during CPB might influence IL-10 synthesis n 
response to CPB and, at least in part, explain the 
different results we observed compared with results 
in the adult series. Because IL-1 production i  vitro 
has been shown to be inhibited by hypothermia, 2 the 
latter, by enhancing IL-10 synthesis, could have a 
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positive influence on cytokine balance during CPB. 
The protective ffect of high circulating IL-10 levels 
after CPB cannot be assessed in our patients be- 
cause IL-10 levels correlate with postoperative mor- 
bidity, as suggested by the relationship between 
Pao JF io  2 calculated during the first postoperative 
day and maximal IL-10 levels. Similar observations 
have been made in adult patients with sepsis in 
whom circulating IL-10 levels correlated with the 
presence of septic shock9  
In conclusion, our study demonstrates that, in 
addition to proinflammatory c tokine release, signif- 
icant secretion of the antiinflammatory cytokine 
IL-10 occurs in infants undergoing CPB. The corre- 
lation between circulating IL-10 levels and degree of 
hypothermia suggests a modulating role of hypo- 
thermia in IL-10 production or secretion, or both. 
IL-10, by down-regulating the production of proin- 
f lammatory cytokines, may play a protective role in 
patients undergoing cardiac operations. 
We thank Karen Buro, DiplMath, for advice in statis- 
tical analysis, our colleagues from the anesthesiologist and 
perfusionist staff, and the nurses from the pediatric inten- 
sive care unit for their help during the study. 
REFERENCES 
1. Casey WF, Hauser G J, Hannallah RS, et al. Circulating 
endotoxin and tumor necrosis factor during pediatric 
cardiac surgery. Crit Care Med 1992;20:1090-6. 
2. Haeffner-Cavaillon N, Rousselier N, Ponzio O, et al. Induction 
of interleukin-1 production i  patients undergoing cardiopul- 
monary bypass. J THORAC CARDIOVASC SURG 1989;98:1100-6. 
3. Steinberg JB, Kapelanski DP, Olson JD, et al. Cytokine and 
complement levels in patients undergoing cardiopulmonary 
bypass. J THORAC CARDIOVASC SURG 1993;106:1008-16. 
4. Kalfin RE, Engelman RM, Ronsou JA, et al. Induction of 
interleukin-8 expression during cardiopulmonary bypass. Cir- 
culation 1993;88:401-6. 
5. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of 
the proinflammatory c tokines to myocardial ischemia nd 
dysfunction after uncomplicated coronary revascularization. 
J THORAC CARDIOVASC SURG 1994;108:626-35. 
6. Kirklin JK, Westaby S, Blackstone E, et al. Complement and 
the damaging effect of cardiopulmonary b pass. J THORAC 
CARDIOVASC SURG 1983;86;845-57. 
7. Seghaye MC, Duchateau J, Grabitz RG, et al. Complement 
activation during cardiopulmonary b pass in infants and 
children: relation to postoperative multiple organ failure. J
THORAC CARDIOVASC SURG 1993;106:978-87. 
8. Tracey KJ, Cerami A. Tumor necrosis factor: an updated 
review of its biology. Crit Care Med 1993;21:$415-22. 
9. Casey LC. Role of cytokines in the pathogenesis of cardio- 
pulmonary-induced multisystem organ failure. Ann Thorac 
Surg 1993;56:$92-6. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 3 
Seghaye t al. 5 5 3 
10. Van Damme J. Interleukin-8 and related molecules. In: 
Thomson A, ed. The cytokine handbook. London: Academic 
Press Limited, 1991:201-14. 
11. Smith WB, Gamble JR, Clark-Lewis I, et al. Interleukin-8 
induces neutrophil transendothelial migration. Immunology 
1991;72:65-72. 
12. Metinko AP, Kunkel SL, Standiford TJ, et al. Anoxia- 
hyperoxia induces monocyte-derived interleukin-8. J Clin 
Invest 1992;90:791- 8.
13. Vilcek J, Le J. Immunology of cytokines: an introduction. In: 
Thomson A, ed. The cytokine handbook. London: Academic 
Press Limited, 1991:1-17. 
14. Moore KW, O'Garra A, de Waal Malefyt R, et al. Interleu- 
kin-10. Annu Rev Immunol 1993;11:165-90. 
15. Sironi M, Munoz C, Pollicino T, et aL Divergent effects of 
interleukin-10 on cytokine production by mononuclear 
phagocytes and endothelial cells. Eur J Immunol 1993;23: 
2692-5. 
16. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits 
cytokine production by activated macrophages. J Immunol 
1991;147:3815-22. 
17. Cassatella MA, Meda L, Bonora S, et al. Interleukin-10 
(IL-10) inhibits the release of proinflammatory c tokines 
from human polymorphonuclear leukocytes: evidence for an 
autocrine role of tumor necrosis factor and IL-1 in mediating 
the production of IL-8 triggered by lipopolysaccharide. J Exp 
Med 1993;178:2207-11. 
18. Rennick D, Berg D, Holland G, et al. Interleukin-10: an 
overview. Prog Growth Factor Res 1992;4:207-27. 
19. Cassatella MA, Meda L, Gasperini S, etal. Interleukin-10 
(IL-10) upregulates IL-1 receptor antagonist production 
from lipopolysaccharide-stimulated human polymorphonu- 
clear leukocytes by delaying mRNA degradation. J Exp Med 
1994;179:1695-9. 
20. G6rard C, Bruyns C, Marchant A, et al. Interleukin-10 
reduces the release of tumor necrosis factor and prevents 
lethality in experimental endotoxemia. J Exp Med 1993;177: 
547-50. 
21. Pradier O, G6rard C, Delvaux A, et al. Interleukin-10 inhibits 
the induction of monocyte procoagulant activity by bacterial 
lipopolysaccharide. Eur J Immunol 1993;23:2700-3. 
22. Mulligan MS, Jones ML, Vaporciyan AA, et al. Protective 
effects of IL-4 and IL-10 against immune complex-induced 
lung injury. J Immunol 1993;151:5666-74. 
23. Marchant A, Devi6re J, Byl B, et al. Interleukin-10 production 
during septicaemia. Lancet 1994;343:707-8. 
24. Derkx B, Marchant A, Goldmann M, et al. High levels of 
interleukin-10 during the initial phase of fulminant meningo- 
coccal septic shock. J Infect Dis 1995;171:229-32. 
25. van der Poll T, Jansen J, Levi M, et al. Regulation of 
interleuldn 10 release by tumor necrosis factor in human and 
chimpanzees. J Exp Med 1994;180:1985-8. 
26. Tabardel Y, Duchateau J, Schmartz D, et al. Corticosteroids 
increase blood interleukin-10 levels during cardiopulmonary 
bypass in men. Surgery [In press]. 
27. Nicolas F, Daniel JP, Bruniaux J, et al. Conventional car- 
diopulmonary bypass in neonates: a physiological ap- 
proach-10 years' experience at Marie-Lannelongue Hospi- 
tal. Perfusion 1994;9:41-8. 
28. Finn A, Naik S, Klein N, et al. Interleukin-8 release and 
neutrophil degranulation after pediatric cardiopulmonary 
bypass. J THORAC CARDIOVASC SURG 1993;105:234-41. 
29. Frering B, Philip I, Dehoux M, et al. Circulating cytokines in 
patients undergoing normothermic cardiopulmonary b pass. 
J THORAC CARDIOVASC SUR6 1994;108:636-41. 
30. Kawamura T, Wakusawa R, Okada K, et al. Elevation of 
cytokines during open heart surgery with cardiopulmonary 
bypass: participation of interleukin 8 and 6 in reperfusion 
injury. Can J Anaesth 1993;40:1016-21. 
31. Tracey KJ. TNF and Mae West or: death from too much of 
a good thing. Lancet 1995;345:75-6. 
